Related Experiment Video

Updated: Nov 3, 2025

Isolation and Characterization of RNA-Containing Exosomes
09:43

Isolation and Characterization of RNA-Containing Exosomes

Published on: January 9, 2012

100.0K

The roles of tumor-derived exosomes in altered differentiation, maturation and function of dendritic cells

Reza Hosseini1, Leila Asef-Kabiri2, Hassan Yousefi3

  • 1Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Molecular Cancer
|June 3, 2021
PubMed

Insights

Tumor-derived exosomes (TDEs) suppress anti-tumor immunity by altering dendritic cells (DCs). Understanding these mechanisms can guide novel cancer immunotherapies and DC-based vaccination strategies.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cellular Biology

Background:

  • Tumor-derived exosomes (TDEs) carry immunosuppressive factors.
  • Dendritic cells (DCs) are crucial for initiating anti-tumor T cell responses.
  • TDEs can significantly impact DC biology and function.

Purpose of the Study:

  • To elucidate the mechanisms by which TDEs disrupt DC differentiation, maturation, and function.
  • To highlight the therapeutic potential of targeting TDEs in cancer treatment.
  • To review exosome inhibitors for future therapeutic strategies.

Main Methods:

  • Mechanistic investigation of TDE-DC interactions.
  • Review of existing literature on TDEs and DC abnormalities.
  • Analysis of TDE cargo and signaling pathways.

Main Results:

  • TDEs subvert normal DC differentiation and maturation processes.
  • TDEs impair the antigen-presenting capacity of DCs.
  • TDEs contribute to immune evasion in the tumor microenvironment.

Conclusions:

  • TDEs play a critical role in cancer immune evasion by targeting DCs.
  • Targeting TDEs offers a promising strategy for enhancing cancer immunotherapy.
  • Further research into TDEs can lead to improved DC-based vaccination and exosome inhibitor development.
Keywords:
Dendritic cellExosomeImmunityTumor

More Related Videos

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.4K
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

18.4K

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.1K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.1K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.2K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.7K